CNN Sanjay Gupta MD June 15, 2013 20:44:00
See and hopefully will end up lowering the cost of some of these tests. >> so maybe more patients, more woman, for the braca-1 and braca-2 can afford it. it's interesting you can't patent the gene but as you point out you can patent the template that you make from that gene to create the test and other companies can make their own template and that's sort of what drives this competition. cost is also a factor i think and it's still going to be a factor even if it's cheaper because we're still talking about expensive technologies. and that brings up the question, who should get this test, dr. r...
Source: archive.org